Pathology Analysis & Statistics, October 2014

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: cancer, breast cancer, leukemia, more »

1-50 of about 407 000 reports

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 12 800
  • Industry report
  • August 2014
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

  • Industries : Pathology
  • Countries : Europe
Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

  • Industries : Pathology
  • Countries : World
OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • August 2014
  • by Global Data

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, World, Europe
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

  • Industries : Pathology
Autoimmune Disease Diagnostics: Global Markets

Autoimmune Disease Diagnostics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report estimates the global diagnostics market for autoimmune diseases, with CAGR projections for the period 2014 to 2019. Market size estimates for pre-treatment and during-treatment ...

  • Industries : Pathology
  • Countries : World
Blood-Brain Barrier Technologies and Global Markets

Blood-Brain Barrier Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report analyzes the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential, determines its current market status, examines ...

  • Industries : Pathology
  • Countries : World
Malignant Melanoma: KOL Insight

Malignant Melanoma: KOL Insight

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline ...

  • Industries : Pathology
  • Countries : United States
KOL Insight: Multiple Sclerosis

KOL Insight: Multiple Sclerosis

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will rise ...

  • Industries : Pathology
  • Countries : United States
Payer Insights: Hepatitis C

Payer Insights: Hepatitis C

  • $ 6 495
  • Industry report
  • September 2014
  • by Firstword Pharma

The race is on for the company that can competitively price treatment regimens, share data on clinical benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth ...

  • Industries : Pathology
  • Countries : United States
BCC Research Bitopertin Forecast

BCC Research Bitopertin Forecast

  • $ 5 500
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research forecast report provides quantitative data about the pharmaceutical drug, Bitopertin. The report will help potential customers in making strategic decisions regarding future participation ...

  • Industries : Pathology
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

  • Industries : Pathology
  • Countries : China
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

  • $ 4 995
  • Industry report
  • September 2014
  • by GBI Research

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pathology
  • Countries : World, Australia, India, Japan, China
Global Sleep Apnea Diagnostic and Therapeutic Devices Market

Global Sleep Apnea Diagnostic and Therapeutic Devices Market

  • $ 4 950
  • Industry report
  • September 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Thousands by the following Product Segments: Diagnostic Devices, and Therapeutic Devices. The report ...

  • Industries : Pathology
Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019

Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

The healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based to a value-based one. Growing demand from consumers for improved healthcare quality and greate ...

  • Industries : Pathology
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest ...

  • Industries : Pathology
  • Countries : World
Automotive Occupant Sensing System (OSS) and Whiplash Protection System (WPS) Market for Passenger Cars - by Geography - Trends and Forecasts 2014 - 2019

Automotive Occupant Sensing System (OSS) and Whiplash Protection System (WPS) Market for Passenger Cars - by Geography - Trends and Forecasts 2014 - 2019

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

Traditional passive safety systems such as airbags and seatbelts minimize the risk of injury in an accident. However, car makers are also focusing on the other passive safety systems like occupant sensing ...

  • Industries : Pathology
Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

Over the years, the western blotting market, comprising of instruments and consumables, has witnessed various technological advancements to improve the sensitivity, reproducibility, quantifiability, and ...

  • Industries : Pathology
  • Countries : World
Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. In 2013, the North American ...

  • Industries : Pathology
  • Countries : World
MarketVIEW: Norovirus vaccines

MarketVIEW: Norovirus vaccines

  • $ 4 495
  • Industry report
  • October 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Noroviruses (NVs) called "Norwalk-like viruses" are a group of single-stranded positive sense RNA viruses and members of the family Caliciviridae. NVs are transmitted from human-to-human and are one of ...

  • Industries : Pathology
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023

EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023 Summary Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascula ...

  • Industries : Pathology
  • Countries : Germany, Japan, China, World, United States
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
EpiCast Report: Asthma - Epidemiology Forecast to 2023

EpiCast Report: Asthma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • September 2014
  • by Global Data

EpiCast Report: Asthma - Epidemiology Forecast to 2023 Summary Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term ...

  • Industries : Pathology
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • September 2014
  • by Global Data

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 Summary Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that ...

  • Industries : Pathology
  • Countries : Japan, World
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • August 2014
  • by Global Data

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part ...

  • Industries : Pathology
  • Countries : Japan, China, World, United States, Spain, Italy, France, Germany
Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014. The report provides ...

  • Industries : Pathology
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • August 2014
  • by Firstword Pharma

As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more ...

  • Industries : Pathology
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market Summary GBI Research, a leading business intelligence ...

  • Industries : Pathology
  • Countries : World
About 40 000 reports

Download Unlimited Documents from Trusted Public Sources

Janssen - Company Report, October 2014

  • Imbruvica® (ibrutinib) Supplemental New Drug Application Submit...
  • October 2014
    4 pages
  • Pathology  

  • United States  

View report >

About 100 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

C.R. Bard Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.